ARRJF
Price
$3.50
Change
+$0.43 (+14.01%)
Updated
Sep 25 closing price
Capitalization
927.23M
MAHLY
Price
$18.34
Change
+$0.84 (+4.80%)
Updated
Sep 15 closing price
Capitalization
3.65B
Interact to see
Advertisement

ARRJF vs MAHLY

Header iconARRJF vs MAHLY Comparison
Open Charts ARRJF vs MAHLYBanner chart's image
Arjo AB
Price$3.50
Change+$0.43 (+14.01%)
Volume$100
Capitalization927.23M
Medipal Holdings
Price$18.34
Change+$0.84 (+4.80%)
Volume$146
Capitalization3.65B
ARRJF vs MAHLY Comparison Chart in %
Loading...
ARRJF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MAHLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARRJF vs. MAHLY commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARRJF is a Buy and MAHLY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (ARRJF: $3.50 vs. MAHLY: $18.34)
Brand notoriety: ARRJF and MAHLY are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: ARRJF: 2% vs. MAHLY: 44%
Market capitalization -- ARRJF: $927.23M vs. MAHLY: $3.65B
ARRJF [@Medical Distributors] is valued at $927.23M. MAHLY’s [@Medical Distributors] market capitalization is $3.65B. The market cap for tickers in the [@Medical Distributors] industry ranges from $94.6B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.68B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARRJF’s FA Score shows that 1 FA rating(s) are green whileMAHLY’s FA Score has 0 green FA rating(s).

  • ARRJF’s FA Score: 1 green, 4 red.
  • MAHLY’s FA Score: 0 green, 5 red.
According to our system of comparison, both ARRJF and MAHLY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARRJF’s TA Score shows that 0 TA indicator(s) are bullish while MAHLY’s TA Score has 3 bullish TA indicator(s).

  • ARRJF’s TA Score: 0 bullish, 1 bearish.
  • MAHLY’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, MAHLY is a better buy in the short-term than ARRJF.

Price Growth

ARRJF (@Medical Distributors) experienced а +14.01% price change this week, while MAHLY (@Medical Distributors) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +1.13%. For the same industry, the average monthly price growth was +3.16%, and the average quarterly price growth was +3.38%.

Industries' Descriptions

@Medical Distributors (+1.13% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MAHLY($3.65B) has a higher market cap than ARRJF($927M). ARRJF has higher P/E ratio than MAHLY: ARRJF (20.84) vs MAHLY (14.12). MAHLY (14.090) and ARRJF (14.007) have similar YTD gains . MAHLY has higher annual earnings (EBITDA): 100B vs. ARRJF (1.97B). MAHLY has more cash in the bank: 251B vs. ARRJF (766M). MAHLY has higher revenues than ARRJF: MAHLY (3.6T) vs ARRJF (11.3B).
ARRJFMAHLYARRJF / MAHLY
Capitalization927M3.65B25%
EBITDA1.97B100B2%
Gain YTD14.00714.09099%
P/E Ratio20.8414.12148%
Revenue11.3B3.6T0%
Total Cash766M251B0%
Total Debt1.19BN/A-
FUNDAMENTALS RATINGS
ARRJF vs MAHLY: Fundamental Ratings
ARRJF
MAHLY
OUTLOOK RATING
1..100
4647
VALUATION
overvalued / fair valued / undervalued
1..100
17
Undervalued
91
Overvalued
PROFIT vs RISK RATING
1..100
10087
SMR RATING
1..100
8452
PRICE GROWTH RATING
1..100
4749
P/E GROWTH RATING
1..100
5245
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ARRJF's Valuation (17) in the null industry is significantly better than the same rating for MAHLY (91). This means that ARRJF’s stock grew significantly faster than MAHLY’s over the last 12 months.

MAHLY's Profit vs Risk Rating (87) in the null industry is in the same range as ARRJF (100). This means that MAHLY’s stock grew similarly to ARRJF’s over the last 12 months.

MAHLY's SMR Rating (52) in the null industry is in the same range as ARRJF (84). This means that MAHLY’s stock grew similarly to ARRJF’s over the last 12 months.

ARRJF's Price Growth Rating (47) in the null industry is in the same range as MAHLY (49). This means that ARRJF’s stock grew similarly to MAHLY’s over the last 12 months.

MAHLY's P/E Growth Rating (45) in the null industry is in the same range as ARRJF (52). This means that MAHLY’s stock grew similarly to ARRJF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARRJFMAHLY
RSI
ODDS (%)
Bearish Trend 2 days ago
29%
Bearish Trend 2 days ago
59%
Stochastic
ODDS (%)
N/A
Bearish Trend 2 days ago
39%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
44%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
28%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
13%
Bullish Trend 2 days ago
35%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
13%
Bullish Trend 2 days ago
35%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 6 days ago
30%
View a ticker or compare two or three
Interact to see
Advertisement
ARRJF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MAHLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FUND8.300.04
+0.52%
Sprott Focus Trust
NMZ10.460.03
+0.29%
Nuveen Municipal High Income Opportunity Fund
XXCH29.56-0.11
-0.37%
Direxion Daily MSCI Em Mkt Ex Chn Bl 2X
MXE11.84-0.04
-0.38%
Mexico Equity and Income Fund (The)
HOOG84.91-1.31
-1.52%
Leverage Shares 2X Long HOOD Daily ETF

ARRJF and

Correlation & Price change

A.I.dvisor tells us that ARRJF and COSM have been poorly correlated (+5% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ARRJF and COSM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARRJF
1D Price
Change %
ARRJF100%
N/A
COSM - ARRJF
5%
Poorly correlated
-0.92%
MAHLY - ARRJF
2%
Poorly correlated
N/A
PDRX - ARRJF
0%
Poorly correlated
N/A
AMFPF - ARRJF
0%
Poorly correlated
N/A
MEPDF - ARRJF
0%
Poorly correlated
N/A
More

MAHLY and

Correlation & Price change

A.I.dvisor tells us that MAHLY and MEPDF have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MAHLY and MEPDF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MAHLY
1D Price
Change %
MAHLY100%
N/A
MEPDF - MAHLY
9%
Poorly correlated
N/A
ZYXI - MAHLY
5%
Poorly correlated
-1.36%
ARRJF - MAHLY
2%
Poorly correlated
N/A
SHPMF - MAHLY
2%
Poorly correlated
N/A
NSVGF - MAHLY
2%
Poorly correlated
N/A
More